Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
A607362-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $119.90 | |
A607362-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $189.90 | |
A607362-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $379.90 | |
A607362-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $599.90 |
Synonyms | 3-Amino-6-chloro-5-dimethylamino-N-2-pyridinylpyrazinecarboxamide hydrochloride |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of mGlu 5 receptor |
Product Description |
ACDPP hydrochloride is a specific mGluR5 antagonist. ACDPP partially bolcks the increase of fragile X mental retardation protein (FMRP) caused by DHPG (HY-12598A) (group I mGluR Agonist)。
|
Ki Data | mGlu-5: Ki= 0.3 μM |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 3-amino-6-chloro-5-(dimethylamino)-N-pyridin-3-ylpyrazine-2-carboxamide;hydrochloride |
---|---|
INCHI | InChI=1S/C12H13ClN6O.ClH/c1-19(2)11-9(13)17-8(10(14)18-11)12(20)16-7-4-3-5-15-6-7;/h3-6H,1-2H3,(H2,14,18)(H,16,20);1H |
InChi Key | CXIHLPLRTFPHKX-UHFFFAOYSA-N |
Canonical SMILES | CN(C)C1=NC(=C(N=C1Cl)C(=O)NC2=CN=CC=C2)N.Cl |
Isomeric SMILES | CN(C)C1=NC(=C(N=C1Cl)C(=O)NC2=CN=CC=C2)N.Cl |
PubChem CID | 16759168 |
Molecular Weight | 329.19 |
PubChem CID | 16759169 |
---|---|
ChEMBL Ligand | CHEMBL1616372 |
GPCRdb Ligand | ACDPP |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
F2426311 | Certificate of Analysis | Mar 14, 2024 | A607362 |
F2426312 | Certificate of Analysis | Mar 14, 2024 | A607362 |
F2426324 | Certificate of Analysis | Mar 14, 2024 | A607362 |
F2426325 | Certificate of Analysis | Mar 14, 2024 | A607362 |
F2426326 | Certificate of Analysis | Mar 14, 2024 | A607362 |
F2426327 | Certificate of Analysis | Mar 14, 2024 | A607362 |
F2426328 | Certificate of Analysis | Mar 14, 2024 | A607362 |
F2426329 | Certificate of Analysis | Mar 14, 2024 | A607362 |
Solubility | Soluble in DMSO (100 mM). |
---|---|
Refractive Index | n20D~1.71 (Predicted) |